By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


apceth Biopharma 

Max-Lebsche-Platz 30

München    D-81377  Germany
Phone: 49-0-89-7009608 - 0 Fax: 49-0-89-7009608– 30


apceth Biopharma is a pioneering clinical stage biopharmaceutical company and a successful contract development & manufacturing organization (CDMO) for complex cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs) located in Munich, Germany.

The company was founded in 2007 as apceth GmbH & Co. KG. It is owned by the investors and the scientific founders.




CEO: Christine Günther

CFO: Dusan Kosijer

CTO: Ulrike Verzetnitsch


Please click here for apceth job opportunities.

Key Statistics

Email: n/a
Ownership: Private

Web Site: apceth Biopharma


Company News
apceth Biopharma Appoints Dusan Kosijer As Chief Financial Officer 5/31/2017 11:04:36 AM
bluebird bio (BLUE) And apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement 12/15/2016 8:00:29 AM
Cynata Enters License Option Agreement With Apceth GmbH 5/9/2016 7:21:52 AM
Apceth GmbH And University of Cologne To Join Forces On Combination Cellular Immunotherapies For Cancer 7/10/2015 9:05:57 AM
Apceth GmbH Expands Further Its GMP Manufacturing Business 6/22/2015 8:36:54 AM
Apceth GmbH Names Ulrike Verzetnitsch As Chief Technical Officer 4/23/2015 10:28:24 AM
Apceth GmbH Initiates Phase II Clinical Trial For Pioneering Engineered Cell Therapy To Treat Gastrointestinal Cancer 3/26/2015 7:18:55 AM
Apceth GmbH 's Ground-Breaking First-In-Man, First-In-Class Clinical Trial In Oncology With Genetically Modified Mesenchymal Stem Cells Is Now Enrolling 1/23/2014 10:36:54 AM
Apceth GmbH Names Dr Stefanos Theoharis Chief Business Officer 9/5/2013 9:47:16 AM
As the First Biopharmaceutical Company Worldwide, Apceth GmbH Receives Approval for a Clinical Trial With Genetically Modified Adult Mesenchymal Stem Cells for the Treatment of Cancer 6/13/2013 9:03:54 AM